No Data
No Data
AstraZeneca Target Cut to GBP120 From GBP140 by Intron Health
AstraZeneca Cut to Hold From Buy by Intron Health
BenevolentAI to Present on Explainable AI for Drug Discovery at BioTechX Europe 2024
CSPC Pharma rose more than 6% in early trading. The group signed an exclusive licensing agreement with AstraZeneca.
CSPC Pharma (01093) rose 5.51% in early trading, now trading at 7.09 Hong Kong dollars, with a turnover of 0.585 billion Hong Kong dollars. CSPC Pharma has issued an announcement.
Biden Administration Unveils Plan To Provide Generic Drugs for $2 to Medicare Recipients
Astrazeneca (AZN) Loses -5.29% in 4 Weeks, Here's Why a Trend Reversal May Be Around the Corner